Pestivirus control programs: how far have we come and where are we going?

被引:67
|
作者
Moennig, Volker [1 ]
Becher, Paul [1 ]
机构
[1] Univ Vet Med, Inst Virol, Dept Infect Dis, D-30559 Hannover, Germany
关键词
bovine viral diarrhea; classical swine fever; pestivirus control; BOVINE VIRAL DIARRHEA; CLASSICAL SWINE-FEVER; VIRUS BVDV INFECTIONS; ORAL IMMUNIZATION; FETAL PROTECTION; VACCINATION; CATTLE; VACCINES; DISEASE; ERADICATION;
D O I
10.1017/S1466252315000092
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Classical swine fever (CSF) is endemic in large parts of the world and it is a major threat to the pig industry in general. Vaccination and stamping out have been the most successful tools for the control and elimination of the disease. The systematic use of modified live vaccines (MLV), which are very efficacious and safe, has often preceded the elimination of CSF from regions or countries. Oral vaccination using MLV is a powerful tool for the elimination of CSF from wild boar populations. Bovine virus diarrhea (BVD) is endemic in bovine populations worldwide and programs for its control are only slowly gaining ground. With two genotypes BVD virus (BVDV) is genetically more diverse than CSF virus (CSFV). BVDV crosses the placenta of pregnant cattle resulting in the birth of persistently infected (PI) calves. PI animals shed enormous amounts of virus for the rest of their lives and they are the reservoir for the spread of BVDV in cattle populations. They are the main reason for the failure of conventional control strategies based on vaccination only. In Europe two different approaches for the successful control of BVD are being used: Elimination of PI animals without or with the optional use of vaccines, respectively.
引用
收藏
页码:83 / 87
页数:5
相关论文
共 50 条
  • [31] How far have we come?
    Elston, Harry J.
    JOURNAL OF CHEMICAL HEALTH & SAFETY, 2014, 21 (05): : 1 - 1
  • [32] How Far We Have Come
    Varvares, Mark A.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2022, 148 (05) : 395 - 396
  • [33] Ventilator Modes Where Have We Come From and Where Are We Going?
    Hess, Dean R.
    CHEST, 2010, 137 (06) : 1256 - 1258
  • [34] Feline research: where have we come from and where are we going?
    Sparkes, Andy
    VETERINARY RECORD, 2018, 183 (01) : 17 - 18
  • [35] WHERE WE HAVE COME SO FAR
    Sasek, Otakar
    LISTY CUKROVARNICKE A REPARSKE, 2023, 139 (12):
  • [36] Ophthalmic education: Where have we come from, and where are we going?
    Liesegang, TJ
    Hoskins, D
    Albert, DM
    O'Day, DM
    Spivey, BE
    Sadun, AA
    Parke, DW
    Mondino, BJ
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (01) : 114 - 121
  • [37] Palliative care: Where have we come from and where are we going?
    Brooksbank, Mary
    PAIN, 2009, 144 (03) : 233 - 235
  • [38] Managing sarcoma: where have we come from and where are we going?
    Bleloch, Jenna S.
    Ballim, Reyna D.
    Kimani, Serah
    Parkes, Jeannette
    Panieri, Eugenio
    Willmer, Tarryn
    Prince, Sharon
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2017, 9 (10) : 637 - 659
  • [39] Introduction to the Special Issue on Adolescent and Young Adult Health: Why We Care, How Far We Have Come, and Where We Are Going
    Devine, Katie A.
    Monaghan, Maureen
    Schwartz, Lisa A.
    JOURNAL OF PEDIATRIC PSYCHOLOGY, 2017, 42 (09) : 903 - 909
  • [40] Biomaterials for Testicular Bioengineering: How far have we come and where do we have to go?
    Horvath-Pereira, Bianca de Oliveira
    Almeida, Gustavo Henrique Dona Rodrigues
    da Silva Junior, Leandro Norberto
    do Nascimento, Pedro Gabriel
    Horvath Pereira, Barbara de Oliveira
    Fireman, Joao Victor Barbosa Tenorio
    Pereira, Maria Laura dos Reis Ferre
    Carreira, Ana Claudia Oliveira
    Miglino, Maria Angelica
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14